References
- RobbinsGTripathyVMMisraVNAncient skeletal evidence for leprosy in India (2000 B.C.)PLoS ONE200945e566919479078
- EiglmeierKSimonSGarnierTColeSTThe integrated genome map of Mycobacterium lepraeLepr Rev200172446246911826482
- ShepardCCTemperature optimum of Mycobacterium leprae in miceJ Bacteriol1965905127112755321481
- DesikanKVSreevatsaExtended studies on the viability of Mycobacterium leprae outside the human bodyLepr Rev19956642872958637382
- PortaelsFFissetteKDe RidderKMacedoPMDe MuynckASilvaMTEffects of freezing and thawing on the viability and the ultra-structure of in vivo grown mycobacteriaInt J Lepr Other Mycobact Dis19885645805873065421
- ReaTHModlinRLLeprosyWolffKGoldsmithLAKatzSIGilchrestBAPallerASLeffellDJFitzpatrick’s Dermatology in General Medicine7th edNew YorkMcGraw-Hill200817861796
- DuncanMEMelsomRPearsonJMMenzelSBarnetsonRSA clinical and immunological study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancyInt J Lepr Other Mycobact Dis19835117176683260
- PorritRJOlsenRETwo simultaneous cases of leprosy developing in tattoosAm J Pathol19472380581719970961
- GelberRHLeprosy (Hansen’s Disease)FauciASBraunwaldEKasperDLHauserSLLongoDLJamesonLLoscalzoJHarrison’s Principles of Internal Medicine17th edNew YorkMcGraw-Hill200810211027
- Leprosy Today [webpage on the Internet]GenevaWorld Health Organizationc2011 [cited 2012 May 28]. Available from: http://www.who.int/lep/en/Accessed February 22, 2012
- LevisWRParaskevasLRJacobsonMSpencerJSpencerTMartiniukFEndemic leprosy in New York CityArch Dermatol2011147562462621576589
- TrumanRWSinghPSharmaRProbable zoonotic leprosy in the southern United StatesN Engl J Med2011364171626163321524213
- Leprosy (Hansen’s disease) [webpage on the Internet]Victoria, AustraliaDepartment of Health, Victoria, Australia [updated 2007 February 10; cited 2012 May 8]. Available from: http://ideas.health.vic.gov.au/bluebook/leprosy.aspAccessed April 24, 2012
- Global Health Observatory (GHO), Leprosy [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/gho/neglected_diseases/leprosy/en/index.htmlAccessed February 12, 2012
- Dharmendra Classification of leprosyHastingsRCLeprosyEdinburghChurchill-Livingstone19858899
- SkacelMAntunesSLRodriguesMMThe diagnosis of leprosy among patients with symptoms of peripheral neuropathy without cutaneous lesions: a follow-up studyArq Neuropsiquiatr2000583B80080711018814
- ScollardDMAdamsLBGillisTPKrahenbuhlJLTrumanRWWilliamsDLThe continuing challenges of leprosyClin Microbiol Rev200619233838116614253
- WorobecSMTreatment of leprosy/Hansen’s disease in the early 21st centuryDermatol Ther200922651853719889136
- MeyersWMMycobacterial Infections of the Skin: B Leprosy: I Introduction and EpidemiologyAshworthTGTropical Pathology2nd edNew YorkSpringer1995294296
- MoschellaSLAn update on the diagnosis and treatment of leprosyJ Am Acad Dermatol200451341742615337986
- RidleyDSJoplingWHClassification of leprosy according to immunity. A five-group systemInt J Lepr Other Mycobact Dis19663432552735950347
- RidleyDSJoplingWHA classification of leprosy for research purposesLepr Rev19623311912814492126
- JayalakshmiMBBSHistopathology of skin lesions in leprosyMalaysian J Pathol198033945
- LockwoodDNLeprosy elimination-a virtual phenomenon or a reality?BMJ200232473521516151812077045
- Diagnosis of leprosy [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/lep/diagnosis/en/Accessed February 24, 2012
- The “Final Push” strategy for elimination [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/lep/strategy/en/Accessed April 25, 2012
- WHO Model Prescribing Information: Drugs Used in Leprosy [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://apps.who.int/medicinedocs/en/d/Jh2988e/4.html#Jh2988e.4Accessed April 24, 2012
- EbenezerGJSuneethaSMohandasRArunthathiSMultibacillary nerve histology in clinically diagnosed borderline tuberculoid leprosy patientsInt J Lepr Other Mycobact Dis19966433113158862266
- WHO roadmap inspires unprecedented support to defeat neglected tropical diseases [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/neglected_diseases/London_meeting_follow_up/en/Accessed March 12, 2012
- MonotMHonoréNGarnierTComparative genomic and phylogeographic analysis of Mycobacterium lepraeNat Genet200941121282128919881526
- WilliamsDLPittmanTLDeshotelMOby-RobinsonSSmithIHussonRMolecular basis of the defective heat stress response in Mycobacterium lepraeJ Bacteriol2007189248818882717933896
- GuliaAFriedIMassoneCNew insights in the pathogenesis and genetics of leprosyF1000 Med Rep20102
- History of the National Hansen’s Disease (Leprosy) Program [webpage on the Internet]US Department of Health and Human Services: Health Resources and Services Administration Available from: http://www.hrsa.gov/hansensdisease/history.htmlAccessed 18 June, 2012
- WilliamsDLGillisTPMolecular detection of drug resistance in Mycobacterium lepraeLepr Rev200475211813015282962
- Guidelines for Global Surveillance of Drug Resistance in Leprosy [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.searo.who.int/catalogue/2005-2011/leprosy.htmAccessed April 29, 2012
- SinghPColeSTMycobacterium leprae: genes, pseudogenes and genetic diversityFuture Microbiol201161577121162636
- JamesWDBergerTGElstonDMHansen’s DiseaseJamesWDBergerTGElstonDMAndrews’ Diseases of the Skin: Clinical Dermatology11th edPhiladelphiaSaunders Elsevier2011334344
- KumarBDograSLeprosyRakelREBopeETConn’s Current Therapy2009PhiladelphiaElsevier Health Sciences200897103
- WHO recommended MDT regimens [webpage on the Internet] GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/lep/mdt/regimens/en/Accessed February 28, 2012
- FischerJHWestDPWorobecSMEvaluation of a continual compliance monitoring program for dapsone in an outpatient Hansen’s disease clinicInt J Lepr Other Mycobact Dis19865445175243819528
- DepsPDNasserSGuerraPSimonMBirshner RdeCRodriguesLCAdverse effects from multi-drug therapy in leprosy: a Brazilian studyLepr Rev200778321622218035772
- Recommended Treatment Regimens [webpage on the Internet]RockvilleUS Department of Health and Human Services [cited 2012 May 28]. Available from: http://www.hrsa.gov/hansensdisease/diagnosis/recommendedtreatment.htmlAccessed March 6, 2012
- ILEPEarly Detection treatment of reversal reaction under field conditions. ILEP Technical Bulletin [serial on the Internet]20114 cited 2012 May 2812 [about 3 p]. Available from: http://www.ilep.org.uk/fileadmin/uploads/Documents/Technical_Bulletins/tb12eng.pdfAccessed May 28, 2012
- LegendreDPMuznyCASwiatloEHansen’s disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactionsPharmacotherapy2012321273722392826
- KahawitaIPWalkerSLLockwoodDNLeprosy type 1 reactions and erythema nodosum leprosumAn Bras Dermatol20088317582
- FaberWRJensemaAJGoldschmidtWFTreatment of recurrent erythema nodosum leprosum with infliximabN Engl J Med2006355773916914716
- GreenstoneGThe revival of thalidomide: From tragedy to therapyBC Medical J2011535230233
- Use of clofazimine for treating ENL reactions in leprosy WHO Guide to the management of ENL reactions [webpage on the Internet]GenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/lep/mdt/clofazimine/en/index.htmlAccessed February 12, 2012
- PoojabylaiahMMarneRBVarikkodanRBalaNDandakeriSMartisJRelapses in multibacillary leprosy patients after multidrug therapyLepr Rev200879332032419009982
- A Guide to Leprosy Control 2nd edGenevaWorld Health Organization198840 Available from: http://whqlibdoc.who.int/publications/1988/9241542233_(part1).pdfAccessed February 24, 2012
- www.who.int [homepage on the Internet]MDT: relapse after treatment FAQGenevaWorld Health Organizationc2012 [cited 2012 May 28]. Available from: http://www.who.int/lep/mdt/relapse/en/index.htmlAccessed April 28, 2012
- BalagonMFCellonaRVCruzELong-term relapse risk of multibacillary leprosy after complision of 2 years of multiple drug therapy (WHO-MDT) in Cebu, PhilippinesAm J Trop Med Hyg200981589589919861628
- KaimalSThappaDMRelapse in LeprosyIndian J Dermatol Venereol Leprol200975212613519293498
- Rocha AdaSCunhaMDDinizLMDrug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patientsJ Clin Microbiol20125061912191722495562
- GelberRHLeprosy (Hansen’s Disease)FauciASBraunwaldEKasperDLHarrison’s Principles of Internal Medicine17th edNew YorkMcGraw-Hill2008
- HanXYSeoYHSizerKCA new Mycobacterium species causing diffuse lepromatous leproyAm J Clin Pathol2008130685686419019760
- HanXYSizerKCThompsonEJComparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosisJ Bacteriol2009191196067607419633074
- HanXYSizerKCTanHHIdentification of the leprosy agent Mycobacterium lepromatosis in SingaporeJ Drugs Dermatol201211216817222270197
- Vera-CabreralEscalante-FuentesWGGomez-FloresMCase of diffuse lepromatous leprosy associated with “Mycobacterium lepromatosis”J Clin Microbiol201149124366436822012006
- MatsuokaMBudiawanTAyeKSThe frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and replapsed leprosy patients from Myanmar, Indonesia and the PhillipinesLepr Rev200778434335218309708
- NakataNKaiMMakinoMMutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistanceAntimicrob Agents Chemother201155276276621115799
- BurgosJde la CruzEParedesRAndayaCRGelberRHThe activity of several newer antimicrobials against logarithmically multiplying M. leprae in miceLepr Rev201182325325822125933
- von EssenMRKongsbakMSchjerlingPOlgaardKOdumNGeislerCVitamin D controls T cell antigen receptor signaling and activation of human T cellsNat Immunol20104114344349 Epub 2010 Mar 720208539
- LiuPTWheelwrightMTelesRMicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosyNat Med201218226727322286305
- Global leprosy situation, 2010Wkly Epidemiol Rec2010853533734820830851
- AráozRHonoréNChoSAntigen discovery: a postgenomic approach to leprosy diagnosisInfect Immun200674117518216368971
- GelukABoboshaKvan der Ploeg-van SchipJJNew biomarkers with revelance to leprosy diagnosis applicable in areas hyperendemic for leprosyJ Immunol2012188104782479122504648
- Kerr-PontesLRBarretoMLEvangelistaCMRodriguesLCHeukelbachJFeldmeierHSocioeconomic, environmental, and behavioural risk factors for leprosy in North-east Brazil: results of a case-control studyInt J Epidemiol2006354994100016645029
- DuthieMSGillisTPReedSGAdvances and hurdles on the way toward a leprosy vaccineHum Vaccin20117111172118322048122